|
|
Volumn 3, Issue 4, 2008, Pages 1015-1021
|
|
A randomized study of extended dosing regimens for initiation of epoetin alfa treatment for anemia of chronic kidney disease
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIANEMIC AGENT;
FERRITIN;
HEMOGLOBIN;
IRON DERIVATIVE;
RECOMBINANT ERYTHROPOIETIN;
TRANSFERRIN;
AGED;
ANEMIA;
ARTICLE;
BLOOD;
CHRONIC DISEASE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ADMINISTRATION;
ERYTHROCYTE TRANSFUSION;
FEASIBILITY STUDY;
FEMALE;
HUMAN;
KIDNEY DISEASE;
MALE;
METABOLISM;
MIDDLE AGED;
MULTICENTER STUDY;
RANDOMIZED CONTROLLED TRIAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
TREATMENT OUTCOME;
UNITED STATES;
AGED;
AGED, 80 AND OVER;
ANEMIA;
CHRONIC DISEASE;
DRUG ADMINISTRATION SCHEDULE;
EPOETIN ALFA;
ERYTHROCYTE TRANSFUSION;
FEASIBILITY STUDIES;
FEMALE;
FERRITINS;
HEMATINICS;
HEMOGLOBINS;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
IRON COMPOUNDS;
KIDNEY DISEASES;
MALE;
MIDDLE AGED;
TRANSFERRIN;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 49149131555
PISSN: 15559041
EISSN: 1555905X
Source Type: Journal
DOI: 10.2215/CJN.05681207 Document Type: Article |
|
Times cited : (33)
|
|
References (9)
|
